| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |